Poor quality drugs: grand challenges in high throughput detection, countrywide sampling, and forensics in developing countries.

Facundo MFernandez; DanaHostetler; KristenPowell; HarparkashKaur; Michael DGreen; Dallas CMildenhall; Paul NNewton; (2011) Poor quality drugs: grand challenges in high throughput detection, countrywide sampling, and forensics in developing countries. The Analyst, 136 (15). pp. 3073-3082. ISSN 0003-2654 DOI: 10.1039/c0an00627k
Copy

Throughout history, poor quality medicines have been a persistent problem, with periodical crises in the supply of antimicrobials, such as fake cinchona bark in the 1600s and fake quinine in the 1800s. Regrettably, this problem seems to have grown in the last decade, especially afflicting unsuspecting patients and those seeking medicines via on-line pharmacies. Here we discuss some of the challenges related to the fight against poor quality drugs, and counterfeits in particular, with an emphasis on the analytical tools available, their relative performance, and the necessary workflows needed for distinguishing between genuine, substandard, degraded and counterfeit medicines.



picture_as_pdf
emss-51984.pdf
subject
Accepted Version
Available under Creative Commons: NC-ND 3.0

View Download

Explore Further

Read more research from the creator(s):

Find work associated with the faculties and division(s):

Find work associated with the research centre(s):

Find work from this publication:

Find other related resources: